Skip to content

Giorgia Sprega

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona 60121, Italy.

4 papers in the library · 40 citations · publishing 2022-2026

Papers

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans

International Journal of Molecular Sciences November 23, 2022 Lourdes Poyatos, Alfredo Fabrizio Lo Faro, Diletta Berardinelli et al. 22 citations

After controlled oral doses of 50–200 mg methylone given to 12 male volunteers, plasma concentrations increased in proportion to dose. Maximum concentrations ranged from 153 ng/mL at the lowest dose to 604 ng/mL at the highest dose. The drug was absorbed rapidly, reaching peak levels in 1.5–2 hours, and had a half-life of about 6 hours. Its metabolite HMMC reached peak concentrations 10–14 times lower than methylone. Unlike MDMA, methylone showed linear pharmacokinetics across the dose range. A validated LC-MS/MS method was used to measure methylone, MDMA, and their metabolites in plasma.

Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.

Journal of pharmaceutical and biomedical analysis January 20, 2024 Alfredo Fabrizio Lo Faro, Giorgia Sprega, Diletta Beradinelli et al. 14 citations

Enantioselective high-performance liquid chromatography-tandem mass spectrometry methods were developed to quantify MDMA and its phase-1 metabolites HMA, HMMA, and MDA in human plasma, sweat, oral fluid, and urine. Two polysaccharide-based chiral columns achieved baseline separation of most enantiomer pairs: the Lux AMP column separated MDMA, HMA, and HMMA enantiomers but not MDA; the Lux i-Amylose-3 column separated MDMA, HMMA, and MDA enantiomers but not HMA. Analysis took under 4 minutes with one column and under 6 minutes with the other. Both methods were validated and applied to biological fluids, confirming enantioselective metabolism of MDMA.

Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.

Journal of pharmaceutical and biomedical analysis June 15, 2024 Giorgia Sprega, Giorgi Kobidze, Alfredo Fabrizio Lo Faro et al. 4 citations

An improved chiral LC-MS/MS method separates all four pairs of enantiomers of MDMA and its major phase-1 metabolites (HMA, HMMA, MDA) on a single Lux AMP column within six minutes, using an optimized mobile phase and column dimensions. The method was applied to human plasma, oral fluid, and urine. In urine, hydrolysis of glucuronides with hydrochloric acid or glucuronidase was tested to evaluate effects on the concentration and enantiomeric distribution of the hydroxy metabolites HMA and HMMA.

HPLC-MS/MS stereoselective determination and quantification of MDMA and its phase-1 metabolite in human oral fluid samples: estimation of consumption time.

Journal of analytical toxicology March 15, 2026 Aurora Balloni, Sarah M R Wille, Giorgia Sprega et al.

MDMA (Ecstasy) is broken down and cleared from the body at different rates for its two mirror-image forms. In oral fluid from 161 samples, the S-(+)-enantiomer of MDMA was eliminated faster (half-life 3.3 hours) than the R-(-)-enantiomer (half-life 4.8 hours). Both reached peak levels within 1.75 hours after taking the drug. For the metabolite MDA, the second enantiomer cleared more quickly (half-life 9.6 hours) than the first (23.8 hours). The ratio of R to S MDMA increased over time, which could help estimate when the drug was taken. In roadside checks, 54.5% of cases had an R/S ratio above 1.5, suggesting use within the prior 24 hours.